References
- Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44:11-24. https://doi.org/10.4143/crt.2012.44.1.11
- Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465-72. https://doi.org/10.1056/NEJM198506063122301
- Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15. https://doi.org/10.1056/NEJM199103143241101
- Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27:5124-30. https://doi.org/10.1200/JCO.2009.22.0467
- Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40. https://doi.org/10.1056/NEJMoa040694
- Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002;236:75-81. https://doi.org/10.1097/00000658-200207000-00012
- Capirci C, Valentini V, Cionini L, et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72:99-107. https://doi.org/10.1016/j.ijrobp.2007.12.019
- Rosenberg R, Nekarda H, Zimmermann F, et al. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 2008;97:8-13. https://doi.org/10.1002/jso.20844
- Rullier A, Laurent C, Capdepont M, et al. Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma. Am J Surg Pathol 2010;34:562-8. https://doi.org/10.1097/PAS.0b013e3181d438b0
- Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-96. https://doi.org/10.1200/JCO.2005.02.1329
- Song JH, Jang HS, Kim YS, et al. The pathological and clinical effects of preoperative chemoradiation in rectal cancer. J Korean Soc Ther Radiol Oncol 2011;29:11-9. https://doi.org/10.3857/jkstro.2011.29.1.11
- Yoon MS, Nam TK, Kim HR, et al. Results of preoperative concurrent chemoradiotherapy for the treatment of rectal cancer. J Korean Soc Ther Radiol Oncol 2008;26:247-56. https://doi.org/10.3857/jkstro.2008.26.4.247
- Park JH, Yoon SM, Yu CS, et al. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. Cancer 2011;117:3703-12. https://doi.org/10.1002/cncr.25943
- Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 1994;30:169-75.
- Janjan NA, Khoo VS, Abbruzzese J, et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999;44:1027-38. https://doi.org/10.1016/S0360-3016(99)00099-1
- Lee JH, Kim SH, Kim JG, et al. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes. Int J Radiat Oncol Biol Phys 2011;81:431-8. https://doi.org/10.1016/j.ijrobp.2010.05.019
- Janjan NA, Crane C, Feig BW, et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001;24:107-12. https://doi.org/10.1097/00000421-200104000-00001
- Park IJ, You YN, Skibber JM, et al. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum 2013;56:135-41. https://doi.org/10.1097/DCR.0b013e318278ff8a
- Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010;28:1638-44. https://doi.org/10.1200/JCO.2009.25.8376
- Gerard JP, Azria D, Gourgou-Bourgade S, et al. Clinical outcome of the ACCORD 12/0405 Prodige 2 randomized trial in rectal cancer. J Clin Oncol 2012;30:4558-65. https://doi.org/10.1200/JCO.2012.42.8771
- Douglass HO Jr, Moertel CG, Mayer RJ, et al. Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1986;315:1294-5. https://doi.org/10.1056/NEJM198611133152014
- Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: result from NSABP R-01. J Natl Cancer Inst 1988;80:21-9. https://doi.org/10.1093/jnci/80.1.21
- Lee JH, Lee JH, Ahn JH, et al. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 2002;20:1751-8. https://doi.org/10.1200/JCO.2002.07.037
- Minsky BD, Conti JA, Huang Y, Knopf K. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 1995;13:1409-16. https://doi.org/10.1200/JCO.1995.13.6.1409
- Choy H, MacRae R, Story M. Basic concepts of chemotherapy and irradiation interaction. In: Halperin EC, Perez CA, Brady LW, editors. Perez and Brady's principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 672-73.
Cited by
- Is elective inguinal radiotherapy necessary for locally advanced rectal adenocarcinoma invading anal canal? vol.9, pp.None, 2013, https://doi.org/10.1186/s13014-014-0296-1
- Carbohydrate Antigen 19-9 Levels Associated with Pathological Responses to Preoperative Chemoradiotherapy in Rectal Cancer vol.15, pp.13, 2014, https://doi.org/10.7314/apjcp.2014.15.13.5383
- Respuesta clínica completa postneoadyuvancia en cáncer de recto estadio III: observación o cirugía vol.29, pp.4, 2013, https://doi.org/10.22516/25007440.436
- KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative Surgery vol.94, pp.31, 2015, https://doi.org/10.1097/md.0000000000001284
- Preoperative chemoradiotherapy followed by transanal local excision for T3 distal rectal cancer: A case report vol.11, pp.4, 2013, https://doi.org/10.3892/etm.2016.3065
- Association of pretreatment serum carcinoembryonic antigen levels with chemoradiation-induced downstaging and downsizing of rectal cancer vol.4, pp.4, 2016, https://doi.org/10.3892/mco.2016.740
- Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials vol.35, pp.3, 2013, https://doi.org/10.3857/roj.2017.00059
- Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy vol.97, pp.48, 2013, https://doi.org/10.1097/md.0000000000013363
- Evaluation of the pathologic response to neoadjuvant treatment in rectal cancer. Experience at the Instituto de Cancerología de Medellín (Colombia, 2011-2017) vol.86, pp.1, 2021, https://doi.org/10.1016/j.rgmxen.2019.11.004